We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

  • Twitter
  • Facebook
  • LinkedIn
Biweekly newsletter of the International Cytokine & Interferon Society

Biweekly newsletter of the International Cytokine & Interferon Society

Signals+ Editors: Daniella Schwartz & Di Yu (Editors in Chief), Saurabh Chattopadhyay, Zhian Chen, Mohamed Saad & Maialen Sebastian-delaCruz

MENU
  • Subscribe
  • Archives ►
    • Archives (Oct. 2023 and before) ►
      • Signals+ October 2022 PDF
      • Signals+ April 2021 PDF
      • Signals+ April 2022 PDF
  • Awards
  • Annual Meeting
  • Member News ►
    • Member Highlights
    • Members in the News
    • Members on the Move
    • New Member Mini-Bios
    • Articles of Interest
    • Reviews of Interest
  • Society News ►
    • President’s Letter
    • Featured Article!
  • Industry News ►
    • Industry Partner News
    • Other Meetings
    • Clinical Trials
  • Subscribe
  • Archives
    • Archives (Oct. 2023 and before)
      • Signals+ October 2022 PDF
      • Signals+ April 2021 PDF
      • Signals+ April 2022 PDF
  • Awards
  • Annual Meeting
  • Member News
    • Member Highlights
    • Members in the News
    • Members on the Move
    • New Member Mini-Bios
    • Articles of Interest
    • Reviews of Interest
  • Society News
    • President’s Letter
    • Featured Article!
  • Industry News
    • Industry Partner News
    • Other Meetings
    • Clinical Trials
HomeYoung Investigators to Watch...2022 Winners2022 Amanda Proudfoot Tribute Award Winner for Advances in Chemokine Biology by a Trainee

2022 Amanda Proudfoot Tribute Award Winner for Advances in Chemokine Biology by a Trainee

April 24, 2022 Young Investigators to Watch...2022 Winners

Learn more about this award here.

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Previous

2022 Sidney & Joan Pestka Graduate Award Winner

Next

Akihiko Yoshimura has been chosen for the 2022 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020)

Young man in a market
Member Highlights

Member Highlight: Meet Kenta Yamamoto

May 19, 2025

I’m an MD/PhD student at the University of Pittsburgh Medical Scientist Training Program, in the laboratory of Dr. Sarah Gaffen, and I’m studying the functions of RNA-binding proteins in T cells mediating inflammatory disease. Previously, I studied spinal cord regeneration in the axolotl salamander with Dr Karen Echeverri and how [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Photo of Dominic Ritacco
New Member Mini-Bios

Dominic Ritacco, Columbia University Medical Center

May 19, 2025

Dominic Ritacco is a graduate student in the Gaudet lab at Columbia University’s Department of Microbiology and Immunology. Dominic received his B.S. in Biochemistry from the University of Wisconsin-Madison. He has previously conducted infectious disease research in the Moormann lab at the University of Massachusetts Chan Medical School and cell [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Banner Image of ICIS President, Sarah Gaffen
Featured Article!

Presidents Message: What the Cytokines Meeting Means to Me

May 5, 2025

If you only attend one conference this year… here’s why it should be Cytokines-2025! Just Right Ever since I attended my first Cytokines conference (Amsterdam, 2000), this meeting has been THE event on my scientific calendar. I admit to being a little biased, but I think Cytokines conferences are perfect [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Person on high peak overlooking the ocean
Member Highlights

Member Highlight: Meet Deanna Santer, Ph.D.

May 5, 2025

My lab is passionate about human interferons and especially type III interferons where there is still a lot to learn about! We are interested in how interferons regulate immune responses. However, when I’m not in the lab I like playing sports and hanging out with my family. Scientist should not [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Clinical Trials, contributed by Howard A. Young
Clinical Trials

Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy (ALPHAGEM)

May 4, 2025

ClinicalTrials.gov ID NCT05941845 Sponsor Centre Hospitalier Universitaire de Nice Information provided by Centre Hospitalier Universitaire de Nice (Responsible Party) Study Overview – Brief Summary Membranous Nephropathy (MN) is a renal autoimmune disease mediated by autoantibodies. Current management is based on the use of immunosuppressive therapies. MN patients with a pro-inflammatory Th17 [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy

Go to mobile version